To evaluate the effectiveness of low-dose radiation therapy (LDRT) and FOLFIRI-bevacizumab (FOLFIRI-B) combination in metastatic colorectal cancer.
Morganti, A. G., Mignogna, S., Caravatta, L., Deodato, F., Macchia, G., Plantamura, N., Massaccesi, M., Picardi, V., Cilla, S., Valentini, V., FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study, <<JOURNAL OF CHEMOTHERAPY>>, 2014; 26 (6): 353-358. [doi:10.1179/1973947813Y.0000000163] [http://hdl.handle.net/10807/63820]
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study
Morganti, Alessio Giuseppe;Mignogna, Samantha;Caravatta, Luciana;Deodato, Francesco;Macchia, Gabriella;Massaccesi, Mariangela;Picardi, Vincenzo;Cilla, Savino;Valentini, Vincenzo
2014
Abstract
To evaluate the effectiveness of low-dose radiation therapy (LDRT) and FOLFIRI-bevacizumab (FOLFIRI-B) combination in metastatic colorectal cancer.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
